BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution manufacturer in global in-vitro diagnostics market since 2010. 

With headquarter located in Taizhou, branch offices sited in Shanghai, Xi’an and Beijing, Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices etc...

Since the inception of International Sales and Marketing Division in June, 2020, under the authorization of international renowned public health organizations and institutions, our products have been being distributed in over 50 countries all over the world and about to come to cover more countries in the near future.

Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.

In the coming year of 2021, we are going to launch more and more high-quality and cost-efficient IVD solution products to the world and there will be more product pipelines coming including STD, Vector-borne and so on.

To Let us look forward to a healthier and better future!

Join us at Bioperfectus Digital Press Conference to know more!

Join Zoom Meeting Link：https://zoom.com.cn/j/84949574333pwd=eHBhUlQrM01EazVXNkU0UDBOYkorUT09